PRO Medicus Limited PMCUF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 31.04% | 30.83% | 29.31% | 25.36% | 28.80% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 31.04% | 30.83% | 29.31% | 25.36% | 28.80% |
| Cost of Revenue | 67.00% | 66.53% | 8.74% | 5.34% | 18.22% |
| Gross Profit | 30.99% | 30.78% | 29.34% | 25.39% | 28.82% |
| SG&A Expenses | 2.99% | 2.82% | 37.48% | 33.28% | 22.63% |
| Depreciation & Amortization | 19.81% | 19.62% | 16.50% | 12.94% | -3.31% |
| Other Operating Expenses | 3,316.70% | 3,315.04% | -243.42% | -239.03% | -117.81% |
| Total Operating Expenses | 24.40% | 24.20% | 26.02% | 22.17% | 13.18% |
| Operating Income | 33.16% | 32.95% | 30.60% | 26.61% | 34.74% |
| Income Before Tax | 65.20% | 64.93% | 234.45% | 224.23% | 31.95% |
| Income Tax Expenses | 67.26% | 66.99% | 237.24% | 226.93% | 30.49% |
| Earnings from Continuing Operations | 64.34% | 64.07% | 233.29% | 223.10% | 32.57% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 64.34% | 64.07% | 233.29% | 223.10% | 32.57% |
| EBIT | 33.16% | 32.95% | 30.60% | 26.61% | 34.74% |
| EBITDA | 33.11% | 32.89% | 30.61% | 26.61% | 34.76% |
| EPS Basic | 64.34% | 64.15% | 233.21% | 223.15% | 32.56% |
| Normalized Basic EPS | 34.13% | 33.83% | 29.82% | 25.94% | 30.96% |
| EPS Diluted | 64.44% | 64.11% | 233.27% | 223.19% | 32.54% |
| Normalized Diluted EPS | 34.05% | 33.89% | 29.89% | 25.84% | 30.90% |
| Average Basic Shares Outstanding | -0.01% | -0.01% | 0.01% | 0.01% | 0.03% |
| Average Diluted Shares Outstanding | -0.02% | -0.02% | 0.00% | 0.00% | 0.09% |
| Dividend Per Share | 36.63% | 36.45% | 28.83% | 24.94% | 32.55% |
| Payout Ratio | -0.14% | -0.14% | -0.59% | -0.59% | 0.02% |